ESMO Breast Cancer 2023 Exhibition is the leading platform to showcase the latest research in the field.
This is an outstanding occasion to promote the value of your products and services both in an onsite and online setting.
For information about the exhibition for ESMO Breast Cancer 2023, please download our Exhibition Manuals below:
Download the ESMO Breast Cancer 2023 Virtual Exhibition Manual
Download the ESMO Breast Cancer 2023 Onsite Exhibition Manual
Contacts
Onsite Exhibition Support
MAW (Medizinische Ausstellungs- und Werbegesellschaft)
International Exhibitions & Advertising
Freyung 6
1010 Vienna, Austria
E-mail: maw@media.co.at
Online Exhibition Support
ESMO Breast 2022 Secretariat
ESMO Head Office
E-mail: breast@esmo.org
Official Italian agency for AIFA procedure
AIFA rules are mandatory only for Italian Pharmaceutical Companies that will attend a congress abroad.
Any pharmaceutical company supporting or participating in a congress, is subjected to an authorisation by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124). The request of authorisation must be submitted within 60 days before the starting date of the even.
ESMO advises pharmaceutical companies to contact the Official Agency:
AIM Group International – AIM Education S.r.l.
Contact: Cristina Ghidoli
Via G. Ripamonti, 129
20141 Milan – Italy
Tel.: +39 02 56601 1
Fax.: +39 02 70048585
E-mail: aifa@aimgroup.eu